Cargando…

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Detalles Bibliográficos
Autores principales:	Van Dyck, Christopher H., O'Dell, Ryan S., Mecca, Adam P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175943/ https://www.ncbi.nlm.nih.gov/pubmed/37187779 http://dx.doi.org/10.1002/trc2.12388

Ejemplares similares

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Andrews, J. Scott, et al.
Publicado: (2019)

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023)

Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
por: Hauser, Robert A., et al.
Publicado: (2014)

The Minimal Clinically Important Differences as Well as Statistical Differences of Main Endpoints are Important in Comparing Postoperative Benefits of Different Analgesic Modalities [Letter]
por: Tian, Tian, et al.
Publicado: (2022)

Minimal clinically important difference for daily pedometer step count in COPD
por: Polgar, Oliver, et al.
Publicado: (2021)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Minimal Clinically Important Difference on Parkinson's Disease Sleep Scale 2nd Version
por: Horváth, Krisztina, et al.
Publicado: (2015)

Minimal clinically important difference in idiopathic pulmonary fibrosis
por: Kang, Mohleen, et al.
Publicado: (2021)

Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases
por: Tseng, Henry, et al.
Publicado: (2023)

Minimal clinically important difference for the Fugl-Meyer assessment of the upper extremity in convalescent stroke patients with moderate to severe hemiparesis
por: Hiragami, Shogo, et al.
Publicado: (2019)

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
por: Mecca, Adam P., et al.
Publicado: (2020)

Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
por: Mielke, Michelle M, et al.
Publicado: (2014)

The King’s Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference
por: Sinha, Aish, et al.
Publicado: (2019)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

What is the minimal clinically important difference, and why does it matter?
por: Simões, Maria do Socorro, et al.
Publicado: (2021)

Minimal clinically important difference for impulse oscillometry in adults with asthma
por: Abdo, Mustafa, et al.
Publicado: (2023)

Principal component analysis of synaptic density measured with [(11)C]UCB-J PET in early Alzheimer’s disease
por: O'Dell, Ryan S., et al.
Publicado: (2023)

Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire
por: Kocks, JWH, et al.
Publicado: (2006)

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
por: Pan, Fengfeng, et al.
Publicado: (2023)

Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
por: Dankers, Marloes, et al.
Publicado: (2020)

Minimal important difference of change in patient-specific goals in severe emphysema patients
por: Hartman, Jorine E., et al.
Publicado: (2020)

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference
por: Stacy, Mark, et al.
Publicado: (2019)

Imaging endpoints for clinical trials in Alzheimer’s disease
por: Cash, David M, et al.
Publicado: (2014)

Letter in response to: “The importance of clinical importance when determining the target difference in sample size calculations”
por: Wong, Hubert
Publicado: (2023)

Use of the minimal important difference as a criterion for clinical importance—are we off track?
por: Moosmayer, Stefan
Publicado: (2022)

The Minimal Clinically Important Difference Changes Greatly Based on the Different Calculation Methods
por: Franceschini, Marco, et al.
Publicado: (2023)

The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment
por: Lamb, Christopher A, et al.
Publicado: (2019)

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [(11)C]UCB‐J
por: Mecca, Adam P., et al.
Publicado: (2022)

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus
por: Rai, Sharan K, et al.
Publicado: (2015)

Minimal clinically important difference for grip strength: a systematic review
por: Bohannon, Richard W
Publicado: (2019)

Physical activity in COPD: Minimal clinically important difference for medical events
por: Teylan, Merilee, et al.
Publicado: (2018)

Minimal clinically important difference of Liverpool Elbow Score in elbow arthroplasty
por: Vishwanathan, Karthik, et al.
Publicado: (2017)

Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD
por: Vitacca, Michele, et al.
Publicado: (2020)

Minimal clinically important difference in means in vulnerable populations: challenges and solutions
por: Peacock, Janet L, et al.
Publicado: (2021)

Minimal clinically important difference of the Trapeziometacarpal Arthrosis Symptoms and Disability questionnaire
por: Florczynski, Matthew, et al.
Publicado: (2022)

Minimal clinically important difference for asthma endpoints: an expert consensus report
por: Bonini, Matteo, et al.
Publicado: (2020)

Demystifying the Value of Minimal Clinically Important Difference in the Cardiothoracic Surgery Context
por: Magouliotis, Dimitrios E., et al.
Publicado: (2023)

Sensitivity to change and minimal clinically important difference of the angioedema control test
por: Fijen, Lauré M., et al.
Publicado: (2023)

Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
por: op Bruinink, Davine Hofste, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vcq6d2h01vc11q04mj70mmh0up